The Biocodex story began modestly, bringing Saccharomyces boulardii CNCM I-745® to a therapeutic brand named Precosa / Enterol.
This single celled, non-pathogenic yeast therapeutic has since become the world's number one yeast-based probiotic in the world.
From this scientific and commercial success, Biocodex has built its worldwide company into a diverse pharmaceutical organization with an international portfolio of products.
Biocodex's products are available in over 100 countries on 5 continents with a network of 9 affiliates and 112 partners. To know more about our products, please select your country.
English
Sub title:
Coordinated efforts to develop meaningful healthcare solutions.
Ordre :
2